Background Habitual coffee consumption is protective against coronary heart disease in women; however, it is not clear whether such cardioprotection is conferred on those who have already experienced an acute myocardial infarction (AMI). Our aim was to investigate whether coffee consumption affected mortality after AMI.
Introduction
Coronary heart disease (CHD) continues to be the one of the leading causes of mortality in the UK despite decreasing mortality since the 1970s [1] . It is encouraging that case fatality rates of acute myocardial infarction (AMI) have continued to improve [2] . Coffee is a popular beverage worldwide and a large amount of literature has been published in the last 40 years investigating coffee and its relationship with CHD, with large discrepancies in the results.
A recent meta-analysis by Wu et al. [3] showed that moderate habitual use was associated with a lower risk of CHD in women and found that coffee consumption did not increase the long-term risk of CHD. One area that the meta-analysis did not look at was coffee consumption and its effect on post-AMI mortality. In fact, no metaanalysis has been carried out in this area and limited research has been published investigating this. Different cohort studies have produced conflicting results [4, 5] . However, these were limited to small cohort populations. An analysis of the large GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico) population of over 11 000 patients [6] found an inverse relationship between coffee consumption and cardiovascular events after AMI. However, when the data were adjusted for confounding factors, the relationship was not shown to be significant. Further, the paper did not examine all-cause mortality. A small case-control study looking at 117 cases of sudden cardiac arrest found that heavy coffee consumption (>10 cups per day) was associated with an increased risk of sudden cardiac arrest in patients with pre-existing coronary artery disease [7] . Interestingly, some [8, 9] but not all studies investigating tea consumption and mortality after an AMI have shown that mortality was reduced in tea drinkers [10] . Because of the difference in the published literature on the effect that coffee has on mortality after AMI, we decided to carry out a systematic review and meta-analysis in an attempt to address this question.
Our aim is to test the hypothesis that coffee consumption reduces all-cause mortality after AMI. We carried out a meta-analysis of prospective cohort studies as there were no randomized-controlled trials testing the hypothesis.
Materials and methods

Search strategy
Using a defined-search strategy, electronic databases (MEDLINE and Embase) were searched for papers published between 1946 and June 2015. The following search threads were used: (i) Coffee OR Caffeine; (ii) Myocardial Infarction, myocardial isch*emia, non ST elevation myocardial infarction (NSTEMI), ST elevation myocardial infarction (STEMI), acute coronary syndrome, coronary artery disease OR unstable angina; (iii) Mortality or Survival; (i), (ii) AND (iii). The search terms were linked to Medical Subject Headings and the bibliographies were assessed. We reviewed all abstracts with a relevant title.
Inclusion/exclusion criteria
For inclusion, the articles had to fulfil the following criteria: (i) be prospective cohort studies in design; (ii) report using hazard ratios, odds ratios, risk ratios and reported them with 95% confidence intervals (CIs); (iii) quantify coffee consumption to enable stratification of consumption into groups; (iv) use all-cause mortality as an outcome; and (v) English language articles. Studies were excluded if (i) they were case-control, cross-sectional or retrospective cohort in design; (ii) categories of coffee consumption were not given; and (iii) they included patients with other cardiovascular diseases (e.g. new onset of stroke).
Data extraction and quality assessment
The data were extracted by one investigator, with any uncertainties in eligibility for inclusion being discussed with the investigator's supervisor. For the studies that were relevant and fulfilled the inclusion and exclusion criteria, the following data were extracted: title, author(s), country, publication year, study period, location of study, population sex, age range, factors adjusted for, outcome measure(s), coffee consumption categories, the number of people in each coffee consumption subset and the number of events observed, the hazard ratios for each coffee consumption subset and its 95% CI. If data needed to carry out the analysis were missing, authors were contacted in an attempt to obtain this information [4, 5] .
The quality of the studies was assessed using criteria similar to those used by Pavia et al. [11] and adapted by Wu et al. [3] . The criteria for which each article was assessed had three broad categories, which included selection bias (0-6 points), confounding (0-10 points), information bias (0-5 points) and data analysis quality (0-2.5 points). The criteria used to assess selection bias included sampling population (general or specific), sampling method (random/census or nonrandom), response rate (>75% or not), comparison of who were and were not lost to follow-up, dropout rate (< 25%) and clear inclusion or exclusion criteria. The criterion for assessing confounding was based on whether or not they included different factors in their adjusted hazard ratios. These factors included age, sex, smoking, alcohol, BMI, dietary factors, hypertension and/or diabetes, physical activity, family history of myocardial infarction (MI), education and/or income. Information bias assessment included validation of coffee assessment, methods of coffee assessment (face-to-face interview/self-administered), a clear definition of MI, events assessment methods (selfreport or hospital records) and blinded event assessment with respect to exposure status. The criteria used for assessment of data analysis quality that we used included demographic data provided, statistical analysis of demographic data, precise P value or 95% CI provided, power calculation and test statistic specified or not. The total possible score achievable was 22.5 and the lowest quality score was 0.
Data synthesis
The eligible studies were entered into RevMan5 software package and the statistical methods were those programmed into RevMan 5.1 analysis software (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark).
As the studies found from our search had different categories of coffee consumption, we standardized these categories by creating three groups of coffee drinkers: nondrinkers (0 cups/day), light drinkers (1-2 cups/day) and heavy drinkers (>2 cups/day).
The number in each group and the number of events in each group were extracted. For the dichotomous data, the risk ratio and 95% CIs were calculated. The results from the trials were pooled using the fixed-effects and random-effects models. We tested for heterogeneity with the Cochran Q statistic, which would be considered to be significant if P value is less than 0.10. If significant, a random-effect model would be used to enable generalization of the results and sources of heterogeneity would be investigated. Z-tests were used to test for the overall effect.
Because of the paucity of studies found in our search, we could not carry out a meta-regression analysis using the adjusted risk ratio presented in each study. We attempted to obtain raw data from authors to perform our own adjustment for confounding, but unfortunately these data were not available [4, 5] .
Results
Search results
The MEDLINE and Embase search identified 186 articles; no new studies were identified with searches of the other databases and society proceedings. After removal of duplicates, 138 articles were reviewed. Review of the titles and abstracts identified six studies appropriate for inclusion [12] [13] [14] ; the full texts of these articles were then reviewed for inclusion. Two fulfilled the inclusion criteria for analysis. For details of the search results, see Fig. 1 . This resulted in a cumulative sample size of 3271 patients, of whom 686 patients were not coffee drinkers, 1112 were light coffee drinkers and 1463 were heavy coffee drinkers.
Both of these studies were looking at both men and women after AMI [4, 5] . One of the studies was carried out in the USA [4] and the other was carried out in Sweden [5] . Intake of coffee consumption in the study carried out in the USA [4] was only based on caffeinated coffee, whereas in the Swedish study, it is not specified [5] . However, the authors state that the consumption of decaffeinated coffee in Sweden is unusual; thus, it can be assumed that the majority of coffee intake reported by participants was caffeinated.
The details of the studies included are shown in Table 1 .
Data quality
The mean overall quality score was 18.5, with the scores ranging from 18 to 19. The mean scores for the selection bias, information bias, confounding and data quality assessment subscores were 5, 8.5, 3 and 2, respectively. Both studies adjusted for confounding for age, sex, smoking, alcohol, BMI, hypertension and/or diabetes, education and/or income and physical activity. However, only one paper adjusted for confounding for family history of MI [4] and neither adjusted for confounding for dietary factors.
Both papers provided a clear definition for MI. One of the studies used a face-to-face questionnaire [4] , whereas the other used a self-administered questionnaire [5] . Both studies used clear event criteria using national death registers to ascertain who had died.
Overall results
A statistically significant inverse correlation was observed between coffee drinking and mortality; all three groups showed a significant reduction in risk ratio (95% CI).
Compared with noncoffee drinkers, the pooled risk ratio of mortality after AMI was 0.79 (95% CI: 0.66-0.94, P = 0.008) for light coffee drinkers ( Fig. 2a ) and 0.54 (95% CI: 0.45-0.65, P < 0.00001) for heavy coffee drinkers ( Fig. 2b) . In addition to this, we found that when compared to light coffee drinkers, heavy coffee drinkers (Fig. 2c) were associated with a risk ratio of 0.69 (95% CI: 0.58-0.83, P <0.0001).
Discussion
The overall results from our analysis indicate that there is a statistically significant inverse association between coffee consumption and mortality after an AMI. Compared with noncoffee drinkers, light (1-2 cups/day) and heavy (>2 cups/day) coffee drinkers had a decreased risk of mortality, with the greatest benefit being shown with heavy consumption.
Mechanism of risk reduction
Many biologically active ingredients are known to be present in coffee, with caffeine being the most commonly associated one. However, the mechanism behind how coffee is cardioprotective is unclear, with evidence suggesting different actions as to how this protection is conferred.
One proposed mechanism is that coffee improves endothelial function [15] . In diabetic women, Lopez-Garcia and colleagues found that decaffeinated coffee consumption had an inverse association with E-selectin and C-reactive protein, both of which are recognized inflammatory markers and play a role in the atherogenic process involved with coronary artery disease [16, 17] . In 2008, a study on the same population found this to be true with consumption of caffeinated coffee, suggesting that caffeine is not involved in the mechanism behind this [18, 19] .
Coffee is known to contain many antioxidants that help reduce oxidative stress [20] . These include chlorogenic 1 Did not include all-cause mortality as outcome measure [6] 1 Not accessible [13] Embase-109
MEDLINE-77
Flow chart of the process of study selection from our search results. *These did not investigate the effect coffee consumption has on mortality. Table 1 Study characteristics of prospective cohort studies investigating the effect of coffee consumption on mortality after acute myocardial infarction that were included in the meta- acid, flavonoids and melanoidins, which significantly inhibit lipid oxidation [3, 21] . Coffee also contains lipidsoluble heterocyclic compounds, which include furans, pyrroles and maltol, along with other metabolites such as caffeine, theobromine and xanthine. These are considered to exert a protective effect by quenching hydroxyl radical-generating systems [21] . Conversely, however, it was also found that coffee consumption increases serum cholesterol levels [22] and homocysteine levels [23] , both of which increase cardiovascular risk [24, 25] , thus complicating the matter. The increase in serum cholesterol after coffee consumption is believed to be dependent on the brewing method [26] , with a metaanalysis published in 2001 showing that patients drinking filtered coffee showed little increase in serum cholesterol as opposed to patients drinking unfiltered coffee [22] . This is considered to be mediated by cafestol and kahweol, which tend to be filtered by the filter paper [26] .
The effects of caffeine consumption on vascular tone are rather interestingcaffeine can vasoconstrict [27] by antagonizaton of adenosine receptors [28] , but may also vasodilate by promoting nitric oxide production in the endothelium [29, 30] . In addition to this, there is also believed to be suppression of cyclic guanosine monophosphate degradation in the endothelium, which is considered to potentiate the vasodilatory effect [30, 31] . This action is considered to be mediated by caffeine acting as a phosphodiesterase inhibitor [31] . Umemura et al. [30] theorized that this vasodilatory-vasoconstrictive balance may regulate vascular function, with their results showing an overall increase in peripheral blood pressure after acute caffeine administration. Mukamal et al. [4] Mukamal et al. [5] Mukamal et al. [5] Total (95% Cl) Cytochrome P450 1A2 is the primary metabolizer of caffeine [32] and the cytochrome P450 1A2 genotype has been indicated as a cause of variation between coffee consumption and cardiovascular risk [33] . This may play some role in this mechanism.
Caldeira et al. [34] recently showed that there is no association between caffeine consumption and increased risk of atrial fibrillation [34] . At low doses, it was shown to even exert a potential protective effect [34] . Furthermore, other research has suggested that caffeine does not potentiate ventricular arrhythmias [35, 36] .
Effect of coffee consumption on other clinical endpoints
The large cohort study by Silletta et al. [6] identified in our search was unfortunately inappropriate for inclusion in our meta-analysis because of significant clinical heterogeneity in terms of study endpoints. It was the only study identified in our search to publish the effects of coffee consumption on the risk of stroke and recurrent MI and it is therefore of benefit to highlight the study's result on these other clinical endpoints post-AMI. After adjustment of confounding factors, it was found that increasing coffee consumption did not reduced the risk of having a stoke after AMI. Furthermore, it also shown that the risk of recurrent MI was also not significantly reduced by coffee consumption. Interestingly, however, it did show that there was a trend to suggest that the risk of sudden death was reduced by coffee consumption; however, this was not statistically significant.
Study limitations
Relatively few studies were found that could be included in this meta-analysis. It is unfortunate that the large cohort study by Silletta et al. [6] could not be included in our analysis as this could have influenced our findings because of a large cohort population size. A request for the data needed for inclusion in this study in our analysis was made to the authors, but these were unavailable. They certainly did not report assessment of all-cause mortality in the published paper, but discovered an inverse relationship between coffee consumption and cardiovascular events after AMI in a univariate analysis.
There was no adjustment of confounding factors in the results of the present meta-analysis, but one of the studies [5] meta-analysed showed that heavy coffee consumption did significantly reduce all-cause mortality after adjustment of potential confounding factors and the other study reported this in one of its subanalyses when looking at mortality within 90 days, but did not show a significant relationship overall [4] . The only controlled trial of coffee versus placebo identified in the literature search was a small nonrandomized cross-over study in healthy volunteers [37] .The authors found that coffee enhances HDL-mediated cholesterol efflux in macrophages. Therefore, coffee may have an antiatherogenic property, at least in part by enhancing HDL-mediated cholesterol efflux from macrophages through its plasma phenolic acids.
The overall sample size meta-analysed included over 3200 patients in the present study. The absolute risk reduction associated with heavy coffee drinking compared with noncoffee drinkers was 9% (24 vs. 15%). Thus, only 11 patients needed to be 'treated' with more than two cups of coffee per day to prevent one death after an AMI. The Swedish paper specified a cup volume of 150 ml [5] , but the size (volume) of the cups was not quantified in the other study [4] . Finally, the median follow-up duration differed between the two studies: 3.8 [4] versus 6.9-9.9 years [5] .
A common limitation in many meta-analyses is publication bias and this limitation is also present in our study. We could have attempted to overcome this by searching the grey literature. Although we included conference proceeding searches, we did not have the resources to contact all potential authors to ask whether there are unpublished data on the subject.
Conclusion
Drinking coffee habitually following an AMI was associated with a reduced risk of mortality.
